PBPH vs. CANC

Last updated Jun 24, 2026

PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) and CANC (Tema Oncology ETF) are both Health & Biotech Equities funds. PBPH is passively managed, while CANC is actively managed. A 0.74 correlation means they provide meaningful diversification when combined. PBPH charges 0.13%/yr vs 0.75%/yr for CANC.

Performance

PBPH vs. CANC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) and Tema Oncology ETF (CANC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, PBPH achieves a 2.63% return, which is significantly lower than CANC's 11.49% return.

PBPH

• 1D: 1.41%
• 1M: 0.87%
• YTD: 2.63%
• 6M: 2.11%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

CANC

• 1D: 1.64%
• 1M: 1.56%
• YTD: 11.49%
• 6M: 9.19%
• 1Y: 56.88%
• 3Y*: 132.65%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

PBPH vs. CANC - Yearly Performance Comparison

	2026 (YTD)	2025
PBPH Portfolio Building Block World Pharma and Biotech Index ETF	2.63%	0.74%
CANC Tema Oncology ETF	11.49%	-0.51%

Correlation

The correlation between PBPH and CANC is 0.74, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (All Time) Calculated using the full available price history since Nov 25, 2025	0.74

Return for Risk

PBPH vs. CANC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PBPH

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

CANC

CANC Risk / Return Rank: 85
CANC Sharpe Ratio Rank: 85
CANC Sortino Ratio Rank: 86
CANC Omega Ratio Rank: 74
CANC Calmar Ratio Rank: 93
CANC Martin Ratio Rank: 85

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PBPH vs. CANC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) and Tema Oncology ETF (CANC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	PBPH	CANC	Difference
Sharpe ratio: Return per unit of total volatility	—	2.52	—
Sortino ratio: Return per unit of downside risk	—	3.54	—
Omega ratio: Gain probability vs. loss probability	—	1.40	—
Calmar ratio: Return relative to maximum drawdown	—	6.15	—
Martin ratio: Return relative to average drawdown	—	16.71	—

Drawdowns

PBPH vs. CANC - Drawdown Comparison

The maximum PBPH drawdown since its inception was -11.10%, smaller than the maximum CANC drawdown of -97.53%. Use the drawdown chart below to compare losses from any high point for PBPH and CANC.

Drawdown Indicators

	PBPH	CANC	Difference
Max Drawdown Largest peak-to-trough decline	-11.10%	-97.53%	+86.43%
Max Drawdown (1Y) Largest decline over 1 year	—	-9.30%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-30.27%	—
Current Drawdown Current decline from peak	-5.21%	-53.78%	+48.57%
Average Drawdown Average peak-to-trough decline	-4.36%	-72.94%	+68.58%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	3.41%	—

Volatility

Volatility by Period

	PBPH	CANC	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	6.60%	—
Volatility (6M) Calculated over the trailing 6-month period	—	16.94%	—
Volatility (1Y) Calculated over the trailing 1-year period	17.07%	22.72%	-5.65%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.07%	278.65%	-261.58%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.07%	278.65%	-261.58%

PBPH vs. CANC - Expense Ratio Comparison

PBPH has a 0.13% expense ratio, which is lower than CANC's 0.75% expense ratio.

Dividends

PBPH vs. CANC - Dividend Comparison

PBPH's dividend yield for the trailing twelve months is around 0.09%, more than CANC's 0.05% yield.

Position	TTM	2025	2024	2023
CANC Tema Oncology ETF	0.05%	0.06%	3.00%	0.56%
PBPH Portfolio Building Block World Pharma and Biotech Index ETF	0.09%	0.09%	0.00%	0.00%

Frequently Asked Questions

Can I hold both PBPH and CANC in my portfolio?

PBPH and CANC have a correlation of 0.74, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, PBPH or CANC?

On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, PBPH or CANC?

PBPH is cheaper with a 0.13% expense ratio, compared with 0.75% for CANC.

Which ETF pays a higher dividend yield, PBPH or CANC?

PBPH has the higher dividend yield at 0.09%, compared with 0.05% for CANC.

What is the main difference between PBPH and CANC?

They also come from different issuers: Portfolio Building Block and Tema. Their fees differ too: 0.13% for PBPH and 0.75% for CANC.